Article
PKC signaling in glioblastoma
25 Mar 2013
Abstract excerpt
Glioblastoma Multiforme (GBM) is the most aggressive brain tumor characterized by intratumoral heterogeneity at cytopathological, genomic and transcriptional levels. Despite the efforts to develop new therapeutic strategies the median survival of GBM patients is 12-14 months. Results from large-scale gene expression profile studies confirmed that the genetic alterations in GBM affect pathways controlling cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
